Literature DB >> 18327915

Inhibition mechanism of the acetylcholine receptor by alpha-neurotoxins as revealed by normal-mode dynamics.

Abraham O Samson1, Michael Levitt.   

Abstract

The nicotinic acetylcholine receptor (AChR) is the prototype of ligand-gated ion channels. Here, we calculate the dynamics of the muscle AChR using normal modes. The calculations reveal a twist-like gating motion responsible for channel opening. The ion channel diameter is shown to increase with this twist motion. Strikingly, the twist motion and the increase in channel diameter are not observed for the AChR in complex with two alpha-bungarotoxin (alphaBTX) molecules. The toxins seems to lock together neighboring receptor subunits, thereby inhibiting channel opening. Interestingly, one alphaBTX molecule suffices to prevent the twist motion. These results shed light on the gating mechanism of the AChR and present a complementary inhibition mechanism by snake-venom-derived alpha-neurotoxins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18327915      PMCID: PMC2750825          DOI: 10.1021/bi702272j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

1.  Swiss-PDB Viewer (Deep View).

Authors:  W Kaplan; T G Littlejohn
Journal:  Brief Bioinform       Date:  2001-05       Impact factor: 11.622

2.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  ElNemo: a normal mode web server for protein movement analysis and the generation of templates for molecular replacement.

Authors:  Karsten Suhre; Yves-Henri Sanejouand
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

4.  Protein normal-mode dynamics: trypsin inhibitor, crambin, ribonuclease and lysozyme.

Authors:  M Levitt; C Sander; P S Stern
Journal:  J Mol Biol       Date:  1985-02-05       Impact factor: 5.469

5.  Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the alpha subunit.

Authors:  S J Tzartos; A Kokla; S L Walgrave; B M Conti-Tronconi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

6.  Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61-76 of the alpha subunit.

Authors:  T Barkas; J M Gabriel; A Mauron; G J Hughes; B Roth; C Alliod; S J Tzartos; M Ballivet
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

7.  Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.

Authors:  D M Fambrough; D B Drachman; S Satyamurti
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

8.  Harmonic dynamics of proteins: normal modes and fluctuations in bovine pancreatic trypsin inhibitor.

Authors:  B Brooks; M Karplus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

9.  Dynamics of a small globular protein in terms of low-frequency vibrational modes.

Authors:  N Go; T Noguti; T Nishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Mapping of surface structures of electrophorus acetylcholine receptor using monoclonal antibodies.

Authors:  S J Tzartos; D E Rand; B L Einarson; J M Lindstrom
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

View more
  15 in total

Review 1.  Gating mechanisms in Cys-loop receptors.

Authors:  Jennie M E Cederholm; Peter R Schofield; Trevor M Lewis
Journal:  Eur Biophys J       Date:  2009-04-29       Impact factor: 1.733

Review 2.  Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.

Authors:  Antoine Taly; Pierre-Jean Corringer; Denis Guedin; Pierre Lestage; Jean-Pierre Changeux
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

3.  Specific membrane binding of neurotoxin II can facilitate its delivery to acetylcholine receptor.

Authors:  Dmitry M Lesovoy; Eduard V Bocharov; Ekaterina N Lyukmanova; Yurij A Kosinsky; Mikhail A Shulepko; Dmitry A Dolgikh; Mikhail P Kirpichnikov; Roman G Efremov; Alexander S Arseniev
Journal:  Biophys J       Date:  2009-10-07       Impact factor: 4.033

Review 4.  Emerging approaches to probing ion channel structure and function.

Authors:  Wei-Guang Li; Tian-Le Xu
Journal:  Neurosci Bull       Date:  2012-08       Impact factor: 5.203

Review 5.  End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease.

Authors:  Steven M Sine
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

6.  Gating mechanism of a P2X4 receptor developed from normal mode analysis and molecular dynamics simulations.

Authors:  Juan Du; Hao Dong; Huan-Xiang Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-29       Impact factor: 11.205

7.  Normal mode dynamics of voltage-gated K(+) channels: gating principle, opening mechanism, and inhibition.

Authors:  Moshe M Greenberger; Abraham O Samson
Journal:  J Comput Neurosci       Date:  2014-09-16       Impact factor: 1.621

8.  Stem cell derived phenotypic human neuromuscular junction model for dose response evaluation of therapeutics.

Authors:  Navaneetha Santhanam; Lee Kumanchik; Xiufang Guo; Frank Sommerhage; Yunqing Cai; Max Jackson; Candace Martin; George Saad; Christopher W McAleer; Ying Wang; Andrea Lavado; Christopher J Long; James J Hickman
Journal:  Biomaterials       Date:  2018-02-27       Impact factor: 12.479

9.  Inherent dynamics of the acid-sensing ion channel 1 correlates with the gating mechanism.

Authors:  Huaiyu Yang; Ye Yu; Wei-Guang Li; Fang Yu; Hui Cao; Tian-Le Xu; Hualiang Jiang
Journal:  PLoS Biol       Date:  2009-07-14       Impact factor: 8.029

Review 10.  Seeking structural specificity: direct modulation of pentameric ligand-gated ion channels by alcohols and general anesthetics.

Authors:  Rebecca J Howard; James R Trudell; R Adron Harris
Journal:  Pharmacol Rev       Date:  2014-02-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.